9.96
price up icon2.15%   +0.21
after-market  Dopo l'orario di chiusura:  10.00  0.04   +0.40%
loading

Solid Biosciences Inc Borsa (SLDB) Ultime notizie

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

pulisher
GlobeNewswire Inc.

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

pulisher
GlobeNewswire Inc.

Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug

pulisher
Zacks Investment Research

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

pulisher
GlobeNewswire Inc.

Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday

pulisher
Benzinga

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

pulisher
GlobeNewswire Inc.

Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus

pulisher
Zacks Investment Research

REGENXBIO (RGNX) Soars 15% on Interim Data From DMD Study

pulisher
Zacks Investment Research

Top 4 Health Care Stocks You May Want To Dump In February

pulisher
Benzinga

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Joe Lewis, billionaire owner of Tottenham Hotspur football club, pleads guilty to insider trading

pulisher
MarketWatch

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

pulisher
Zacks Investment Research

Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up

pulisher
Zacks Investment Research

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

pulisher
GlobeNewswire Inc.

Insiders Buying Solid Biosciences And 2 Other Stocks

pulisher
Benzinga

Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why

pulisher
Zacks Investment Research

Why Sarepta's (SRPT) Stock Price Moved Up 17% on Tuesday

pulisher
Zacks Investment Research

Solid Biosciences Announces $109 Million Private Placement

pulisher
GlobeNewswire Inc.

Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up

pulisher
Zacks Investment Research

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Solid Biosciences to Participate at 35th Annual Piper Sandler Healthcare Conference

pulisher
GlobeNewswire Inc.

Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics

pulisher
Zacks Investment Research

Biotech Stock Roundup: BMY's Drug Approval, VRTX & CRSP Gene Therapy Get MHRA Nod

pulisher
Zacks Investment Research

Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND

pulisher
Zacks Investment Research

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga
$79.65
price down icon 1.06%
$160.77
price down icon 0.86%
$147.89
price down icon 1.33%
$29.53
price up icon 1.27%
$356.01
price down icon 0.97%
$92.28
price down icon 0.47%
Capitalizzazione:     |  Volume (24 ore):